Body-clock gene variants were associated with type 2 diabetes and glucose measures
A large review found associations that differed by gene and outcome, with some patterns also varying alongside lifestyle and environmental factors.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Variants in genes involved in the body clock were associated with glucose regulation and type 2 diabetes. The direction depended on the gene and outcome measured. These genetic associations do not show that changing sleep, diet or daily timing prevents type 2 diabetes, or that a particular gene determines an individual's outcome.
This abstract-based account lacks specific variants, reference groups and follow-up periods behind the pooled estimates. The abstract also does not report a trial testing whether changing circadian alignment reduces type 2 diabetes risk.
Genes and outcomes were grouped
Researchers pooled effects from variants within each gene. They examined type 2 diabetes alongside fasting glucose, glucose tolerance, fasting insulin and insulin resistance. These are distinct outcomes and should not be treated interchangeably.
Lifestyle findings need careful interpretation
Some variant associations differed with diet, alcohol use, activity, sleep or daylight duration. That suggests context may matter, but it does not establish that deliberately changing any of these factors would alter the genetic association.
The original publication
The association between clock gene polymorphisms and type 2 diabetes: A systematic review and meta-analysis.
Joshi D, Pigeyre M, Ali MU et al.
Diabetes Metab Syndr · 2025
- PubMed ID
- 40850217
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.